Scott Gottlieb, MD, will take on the new position “effective immediately.” UnitedHealth Group did not say what, if any, steering committee the former FDA lead will sit on. Scott Gottlieb, MD, will take on the new position “effective immediately.” UnitedHealth Group did not say what, if any, steering committee the former FDA lead will sit on. | | |
|
The agency is accused of failing to respond to a records request related to its upcoming review of the legality of abortion pills and interstate prescribing practices. The ACLU is asking a federal judge to enforce FOIA law. The agency is accused of failing to respond to a records request related to its upcoming review of the legality of abortion pills and interstate prescribing practices. The ACLU is asking a federal judge to enforce FOIA law. | | |
|
Democrats want to keep Obamacare going. Republicans want to replace it, ideally with health savings accounts. Regardless of which approach holds sway this week—or whenever—either one would be woefully shortsighted. Democrats want to keep Obamacare going. Republicans want to replace it, ideally with health savings accounts. Regardless of which approach holds sway this week—or whenever—either one would be woefully shortsighted. | | |
|
A Hail Mary attempt by a bipartisan group to extend Affordable Care Act tax credits failed. The new bill contains some reforms, including new reporting requirements for PBMs and support for association health plans. It now faces the Senate. A Hail Mary attempt by a bipartisan group to extend Affordable Care Act tax credits failed. The new bill contains some reforms, including new reporting requirements for PBMs and support for association health plans. It now faces the Senate. | | |
|
The label is the most serious warning the agency can place on pharmaceuticals, denoting substances that carry serious health risks that must be weighed against benefits. CNN was the first to report the news, citing two sources familiar with the matter. The label is the most serious warning the agency can place on pharmaceuticals, denoting substances that carry serious health risks that must be weighed against benefits. CNN was the first to report the news, citing two sources familiar with the matter. | | |
|
In a new data analysis from nine states, the Centers for Disease Control and Prevention found that the protective effect tapers off as juveniles age, with 5-17 year olds seeing fewer trips to urgent care or the emergency room at a rate of 56%. Overall, the agency said evidence shows that COVID-19 vaccines are still effective. In a new data analysis from nine states, the Centers for Disease Control and Prevention found that the protective effect tapers off as juveniles age, with 5-17 year olds seeing fewer trips to urgent care or the emergency room at a rate of 56%. Overall, the agency said evidence shows that COVID-19 vaccines are still effective. | | |
|
Researchers from University of Minnesota found that more than 300 small, rural hospitals didn't even apply for relief. At the same time, many larger, for-profit systems received hundreds of thousands in overpayments. The findings are published in Health Affairs. Researchers from University of Minnesota found that more than 300 small, rural hospitals didn't even apply for relief. At the same time, many larger, for-profit systems received hundreds of thousands in overpayments. The findings are published in Health Affairs. | | |
|
Reaction to the recommendation has been strong and mostly—but not entirely—negative. Reaction to the recommendation has been strong and mostly—but not entirely—negative. | | |
|
HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time. HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time. | | |
|
The bipartisan group of attorneys general is pushing back against Congressional plans to bar states from regulating AI, machine learning and large language models. The bipartisan group of attorneys general is pushing back against Congressional plans to bar states from regulating AI, machine learning and large language models. | | |
|
